Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q1 2025 Earnings

6MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-3.55

-2.48

-1.42

-0.35

Details

Expected EPS

-0.428

Actual EPS

-0.56

Surprise EPS

-0.13

Surprise Percent

+30.84%

Description

Contineum Therapeutics (CTNM) has reported earnings of -0.56 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.